Northrook, IL -- (SBWIRE) -- 03/04/2020 -- The report "Rodenticides Market by Type (Non-Anticoagulants, Anticoagulants (FGAR, SGAR)), End-Use Sector (Agricultural Fields, Warehouses, Urban Centers (Residential, Commercial)), Mode of Application (Pellets, Sprays, Powders), and Region - Global Forecast to 2025", published by MarketsandMarkets is projected to reach USD 5.9 billion by 2025, from USD 4.7 billion in 2019, at a CAGR of 3.7% during the forecast period. The market is driven by factors such as urbanization and industrialization, along with public awareness about chemical-based rodenticides.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189089498

Increasing residential and commercial settings due to the migration of people from rural areas, resulting in the displacement of rats, is one of the major factors affecting the growth of the rodenticides market during the forecast period.

Rodenticides are used for the purpose of killing and repelling rodents from the areas susceptible to damages caused by rats in commercial settings, residential spaces, agricultural fields, and warehouses. People migrating from rural areas to urban centers triggered the rats to displace from their places, and these rats or rodents found their homes near to humans. This created the need for using rodenticides to get rid of these rodents. Furthermore, the increasing awareness among people and the consciousness towards health and hygiene also encouraged them to make use of the rodenticides.

Browse in-depth TOC on "Rodenticides Market"

115 - Tables
48 - Figures
191 - Pages

Across the majority of the developed nation's pesticide registry, anticoagulant rodenticides are the most widely approved products in the market. Active ingredients, such as bromadiolone and brodifacoum, have gained increased popularity among pest control operators for urban application. Thus, the anticoagulants segment dominated the overall rodenticides market, by type, due to the excessive use of second-generation anticoagulants. With the continuous use of first-generation anticoagulants, rodents developed resistance against the active ingredients, which, in turn, led to the development of second-generation anticoagulants. These are majorly being used for killing the rodents due to their efficacy to kill them in a single dose. However, there have been instances of resistance against second-generation anticoagulant rodenticides, and hence, research on better and efficient active ingredients has been taken up by the key manufacturers.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=189089498

North America is projected to dominate the rodenticides market by 2025.

The rodenticides market was dominated by North America in 2018 and is also projected to witness significant growth during the forecast period. This is due to the growing concerns of rodent attacks in the US. According to the Washington Post Company LLC (US), there were about 2 million New York City rats in 2014. According to Rentokil Initial Plc (UK), there are over 20,000 pest control service companies in North America; Orkin, Terminix, Rentokil, and Ecolab occupy a significant share in the market. Among all the pests, according to the same report, rodents were responsible for over 29% of pest incidents in America in 2017, 35% of which were from the North-Eastern region.

This report includes a study of the development strategies, along with the product portfolios of leading companies. It also includes the profiles of the companies in the rodenticide product market. These include BASF SE (Germany), Bayer (Germany), Syngenta (Switzerland), UPL (India), Liphatech Inc. (US), JT Eaton (US), Neogen Corporation (US), Pelgar International (UK), Senestech Inc. (US), Bell Laboratories (US), and Impex Europa (UK). The key players profiled under the rodenticide service market include Rentokil Initial Plc (UK), Terminix (US), Ecolab (US), Anticimex (Sweden), Rollins (US), Truly Nolen (US), and Abell Pest Control (Canada).

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.